Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro

Molecular Therapy

Volumn 19, Issue 2, 2011, Pages 318-325

  Georgieva, Julia V ^a   Kalicharan, Dharamdajal ^a   Couraud, Pierre Olivier ^b,c   Romero, Ignacio A ^d   Weksler, Babette ^e   Hoekstra, Dick ^a   Zuhorn, Inge S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b INSTITUT COCHIN   (France)

^c INSERM   (France)

^d OPEN UNIVERSITY   (United Kingdom)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; POLYETHYLENEIMINE;

ARTICLE; BLOOD BRAIN BARRIER; CELL COMMUNICATION; CELL FATE; CELL INTERACTION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MORPHOLOGY; PROTEIN MODIFICATION; SIGNAL PROCESSING; TRANSCYTOSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 79551648929     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.236     Document Type: Article

References (36)

1. Wolf, AA, Jobling, MG, Wimer-Mackin, S, Ferguson-Maltzman, M, Madara, JL, Holmes, RK et al. (1998). Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia. J Cell Biol 141: 917-927.
2. Tuma, PL and Hubbard, AL (2003). Transcytosis: crossing cellular barriers. Physiol Rev 83: 871-932.
3. Muro, S, Koval, M and Muzykantov, V (2004). Endothelial endocytic pathways: gates for vascular drug delivery. Curr Vasc Pharmacol 2: 281-299.
4. Norkin, LC (2001). Caveolae in the uptake and targeting of infectious agents and secreted toxins. Adv Drug Deliv Rev 49: 301-315.
5. Predescu, SA, Predescu, DN and Malik, AB (2007). Molecular determinants of endothelial transcytosis and their role in endothelial permeability. Am J Physiol Lung Cell Mol Physiol 293: L823-L842.
6. Triguero, D, Buciak, JB, Yang, J and Pardridge, WM (1989). Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci USA 86: 4761-4765.
7. Kumagai, AK, Eisenberg, JB and Pardridge, WM (1987). Absorptive-mediated endocytosis of cationized albumin and a -endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem 262: 15214-15219.
8. Candela, P, Gosselet, F, Miller, F, Buee-Scherrer, V, Torpier, G, Cecchelli, R et al. (2008). Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro. Endothelium 15: 254-264.
9. Fishman, JB, Rubin, JB, Handrahan, JV, Connor, JR and Fine, RE (1987). Receptormediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res 18: 299-304.
10. Descamps, L, Dehouck, MP, Torpier, G and Cecchelli, R (1996). Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am J Physiol 270: H1149-H1158.
11. Zensi, A, Begley, D, Pontikis, C, Legros, C, Mihoreanu, L, Wagner, S et al. (2009). Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J Control Release 137: 78-86.
12. Pardridge, WM, Buciak, JL and Friden, PM (1991). Selective transport of an antitransferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther 259: 66-70.
13. Fukuta, M, Okada, H, Iinuma, S, Yanai, S and Toguchi, H (1994). Insulin fragments as a carrier for peptide delivery across the blood-brain barrier. Pharm Res 11: 1681-1688.
14. Rejman, J, Oberle, V, Zuhorn, IS and Hoekstra, D (2004). Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377: 159-169.
15. Viegas, P, Chaverot, N, Enslen, H, Perrière, N, Couraud, PO and Cazaubon, S (2006). Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-endothelial migration of human monocytes. J Cell Sci 119: 4634-4643.
16. Banks, WA, Robinson, SM, Diaz-Espinoza, R, Urayama, A and Soto, C (2009). Transport of prion protein across the blood-brain barrier. Exp Neurol 218: 162-167.
17. Roth, TF and Porter, KR (1964). Yolk protein uptake in the oocyte of the mosquito Aedes aegypti. l. J Cell Biol 20: 313-332.
18. Tebar, F, Sorkina, T, Sorkin, A, Ericsson, M and Kirchhausen, T (1996). Eps15 is a component of clathrin-coated pits and vesicles and is located at the rim of coated pits. J Biol Chem 271: 28727-28730.
19. Doherty, GJ and McMahon, HT (2009). Mechanisms of endocytosis. Annu Rev Biochem 78: 857-902.
20. Schnitzer, JE, Oh, P, Pinney, E and Allard, J (1994). Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 127: 1217-1232.
21. Parton, RG, Joggerst, B and Simons, K (1994). Regulated internalization of caveolae. J Cell Biol 127: 1199-1215.
22. Aoki, T, Nomura, R and Fujimoto, T (1999). Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp Cell Res 253: 629-636.
23. Orlandi, PA and Fishman, PH (1998). Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 141: 905-915.
24. Olusanya, O, Andrews, PD, Swedlow, JR and Smythe, E (2001). Phosphorylation of threonine 156 of the mu2 subunit of the AP2 complex is essential for endocytosis in vitro and in vivo. Curr Biol 11: 896-900.
25. Shurety, W, Stewart, NL and Stow, JL (1998). Fluid-phase markers in the basolateral endocytic pathway accumulate in response to the actin assembly-promoting drug Jasplakinolide. Mol Biol Cell 9: 957-975.
26. Liu, NQ, Lossinsky, AS, Popik, W, Li, X, Gujuluva, C, Kriederman, B et al. (2002). Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol 76: 6689-6700.
27. Schnatwinkel, C, Christoforidis, S, Lindsay, MR, Uttenweiler-Joseph, S, Wilm, M, Parton, RG et al. (2004). The Rab5 effector Rabankyrin-5 regulates and coordinates different endocytic mechanisms. PLoS Biol 2: E261.
28. Marella, M, Lehmann, S, Grassi, J and Chabry, J (2002). Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J Biol Chem 277: 25457-25464.
29. Rajendran, L, Knölker, HJ and Simons, K (2010). Subcellular targeting strategies for drug design and delivery. Nat Rev Drug Discov 9: 29-42.
30. Brandner, S, Klein, MA and Aguzzi, A (1999). A crucial role for B cells in neuroinvasive scrapie. Transfus Clin Biol 6: 17-23.
31. Lasmézas, CI, Cesbron, JY, Deslys, JP, Demaimay, R, Adjou, KT, Rioux, R et al. (1996). Immune system-dependent and -independent replication of the scrapie agent. J Virol 70: 1292-1295.
32. Banks, WA, Niehoff, ML, Adessi, C and Soto, C (2004). Passage of murine scrapie prion protein across the mouse vascular blood-brain barrier. Biochem Biophys Res Commun 318: 125-130.
33. Tang, Y, Han, T, Everts, M, Zhu, ZB, Gillespie, GY, Curiel, DT et al. (2007). Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model. Gene Ther 14: 523-532.
34. Chang, J, Jallouli, Y, Kroubi, M, Yuan, XB, Feng, W, Kang, CS et al. (2009). Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the bloodbrain barrier. Int J Pharm 379: 285-292.
35. Weksler, BB, Subileau, EA, Perrière, N, Charneau, P, Holloway, K, Leveque, M et al. (2005). Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19: 1872-1874.
36. Costes, SV, Daelemans, D, Cho, EH, Dobbin, Z, Pavlakis, G and Lockett, S (2004). Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J 86: 3993-4003.